FDA Approves Kisqali for Early-Stage Breast Cancer

moderators
moderators Posts: 10,640
edited September 2024 in Targeted Therapy - Before, During, and After

FDA Approves Kisqali for Early-Stage Breast Cancer

September 17, 2024

Kisqali (chemical name: ribociclib) can now be used after surgery in combination with an aromatase inhibitor to treat stage II or stage III hormone receptor-positive, HER2-negative breast cancer with a high risk of recurrence. Read more…

Tagged:

Comments

  • lolasmommy
    lolasmommy Posts: 2

    I have stage 2 lobular breast cancer

    Had right mastectomy followed by radiation Just finished 1st round of kisqali have had low grade fever chills & aches daily. Is this typical & does it get better

Categories